Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients’ Outcome in Basal-Like Breast Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients’ Outcome in Basal-Like Breast Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 7, Pages e0159073
Publisher
Public Library of Science (PLoS)
Online
2016-07-12
DOI
10.1371/journal.pone.0159073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Model for Basaloid Triple-negative Breast Cancer: Behavior In Vivo and Response to Therapy
- (2015) Lisa D Volk-Draper et al. NEOPLASIA
- Estrogen regulates the expression of Ndrg2 in astrocytes
- (2014) Yu-Long Ma et al. BRAIN RESEARCH
- N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial–mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling
- (2014) Myung-Jin Kim et al. CANCER LETTERS
- NDRG2 Controls COX-2/PGE2-Mediated Breast Cancer Cell Migration and Invasion
- (2014) Myung-Jin Kim et al. MOLECULES AND CELLS
- Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers
- (2014) Shingo Nakahata et al. Nature Communications
- Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer
- (2014) L Shen et al. Oncogenesis
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer
- (2013) Akihiro Yamamura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production
- (2012) Sang-seok Oh et al. CARCINOGENESIS
- Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen
- (2012) Jana Jeschke et al. Epigenetics
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Inhibition of Endothelial Cell Proliferation and Tumor Angiogenesis by Up-Regulating NDRG2 Expression in Breast Cancer Cells
- (2012) Ji Ma et al. PLoS One
- NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression
- (2011) Jin Zheng et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- N-mycDownstream-regulated Gene 2, a Novel Estrogen-targeted Gene, Is Involved in the Regulation of Na+/K+-ATPase
- (2011) Yan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma
- (2011) Shi-peng Song et al. MEDICAL ONCOLOGY
- The effect of Ndrg2 expression on astroglial activation
- (2011) Toshiaki Takeichi et al. NEUROCHEMISTRY INTERNATIONAL
- Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro
- (2011) E Noetzel et al. ONCOGENE
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Intermediate filament dynamics and breast cancer: Aberrant promoter methylation of the Synemin gene is associated with early tumor relapse
- (2010) E Noetzel et al. ONCOGENE
- Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells
- (2009) Soo-Kyung Shon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors
- (2009) Victoria C. Foletta et al. JOURNAL OF PHYSIOLOGY-LONDON
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
- (2009) Jessica Kao et al. PLoS One
- Functional and Clinical Evidence for NDRG2 as a Candidate Suppressor of Liver Cancer Metastasis
- (2008) D. C. Lee et al. CANCER RESEARCH
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- How basal are triple-negative breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- Wnt/β-catenin signaling controls development of the blood–brain barrier
- (2008) Stefan Liebner et al. JOURNAL OF CELL BIOLOGY
- N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis
- (2008) N. Liu et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started